5th Asia-Australia Congress on Controversies in Ophthalmology

200120 Shanghai Shi, China
Kongress

5th Asia-Australia Congress on Controversies in Ophthalmology

Asia-Australia COPHy 2019

Datum:
21.02.2019, 19:00 - 23.02.2019, 18:00
Veranstalter:
Comtecmed
Kurzbeschreibung:
We are pleased to announce and invite you to attend the 5th Annual Congress on Controversies Ophthalmology: Asia-Australia (COPHy AA) which will take place in, Shanghai, China, February 21-23, 2019. Topics will include the treatment of retinal diseases such as age-related macular degeneration and diabetic macular edema, the role of anti-VEGF agents versus panretinal photocoagulation in the management of proliferative diabetic retinopathy, polypoidal choroidal vasculopathy and more.
Fortbildungspunkte: 

Fachärzte

Max. Teilnehmer: unbegrenzt
Gebühren ab: 430,00 EUR

Hinweis:
EARLY REGISTRATION
Until Jan 10, 2019

Physicians and Scientists: € 430,00

Physicians and Scientists from surrounding countries**: € 300,00



LATE REGISTRATION
Jan 11 – Feb 12, 2019

Physicians and Scientists: € 520,00

Physicians and Scientists from surrounding countries**: € 365,00




ON-SITE
REGISTRATION
Feb 13, 2019 and On-Site

Physicians and Scientists: € 570,00

Physicians and Scientists from surrounding countries**: € 400,00


Daily Registration:
Chinese Physicians and Scientists: € 140,00
Full Registration: €190,00



** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam

medizinisches Fachpersonal

Max. Teilnehmer: unbegrenzt
Gebühren ab: 330,00 EUR
EarlyBird bis 10.01.2019:

Hinweis:
EARLY
REGISTRATION
Until Jan 10, 2019

Trainees*, Nurses: € 330,00
Trainees*, Nurses from surrounding countries**: € 230,00



LATE
REGISTRATION
Jan 11 – Feb 12, 2019

Trainees*, Nurses: € 400,00
Trainees*, Nurses from surrounding countries**: € 280,00



ON-SITE
REGISTRATION
Feb 13, 2019 and On-Site

Trainees*, Nurses: € 440,00
Trainees*, Nurses from surrounding countries**: € 310,00



Daily Registration:
Chinese Trainees* and Nurses: € 120,00**




* Must be accompanied by documents, under 35 years old.
** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam

Studenten/-innen

Max. Teilnehmer: unbegrenzt
Gebühren ab: 330,00 EUR

Hinweis:
EARLY REGISTRATION
Until Jan 10, 2019

Students: € 330,00
Students from Surrounding Countries**: € 230,00


LATE
REGISTRATION
Jan 11 – Feb 12, 2019

Students: € 400,00
Students from Surrounding Countries**: € 280,00



ON-SITE
REGISTRATION
Feb 13, 2019 and On-Site

Students: € 440,00
Students from Surrounding Countries**: € 310,00


Daily Registration:
Chinese Students: € 120,00**


** Surrounding countries include: Kora, Russia, Mongolia, Kazakhstan, Kyrgyzstan, Tajikistan, Afghanistan, Pakistan, India, Nepal, Bhutan, Myanmar, Laos and Vietnam




für Referenten

Abstract: 31.12.2018
Hinweis:
k.A.
Bemerkungen:
Diese Veranstaltung findet jährlich statt und bietet Fortbildungsmöglichkeiten für Fachärzte, Studenten/-innen und medizinisches Fachpersonal.
Sponsoren und Aussteller:
Veranstaltungsnummer: 27846
Gebühren ab:
ab 330,00
verfügbare Plätze: unbegrenzt
Sprache: Englisch
Simultanübersetzungen:
Chinesisch (Mandarin)
 
Abstract:
31.12.2018
Vom Veranstalter gemeldetes Programm:
  RETINA
   

FRIDAY, FEBRUARY 22, 2019

HALL A
   

08:30-10:00

OPENING SESSION | Big Controversies in Ophthalmology in 2019

Chairs:

Neil Bressler, USA 

08:30-09:00

Debate I: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment

08:30-08:40

Yes: Susan Bressler, USA

08:40-08:50 No
08:50-09:00 Discussion
 

09:00-09:30

Debate II: Neuro-protection in glaucoma: A viable pursuit

09:00-09:10

Yes: Christopher Leung, Hong Kong

09:10-09:20 No
09:20-09:30 Discussion
 

09:30-10:00

Debate III: Atrophine should be used in children to prevent myopia

09:30-09:40

Yes: Tien Yin Wong, Singapore

09:40-09:50

No, not in all cases

09:50-10:00

Discussion
 
10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break
 

10:30-12:00

RETINA I | Choroidal Neovascular Age-related Macular Degeneration

Chairs:

Xiaoxin Li, China; Adrian Koh, Singapore 

10:30-11:00

Debate I: Treat and extend regimens are superior to PRN regimens

10:30-10:40

Yes: Gemmy Cheung, Singapore

10:40-10:50 No: Susan Bressler, USA
10:50-11:00 Discussion
 

11:00-11:30

Debate II: Large submacular hemorrhages typically should be managed initially with surgery, not anti-VEGF injections

11:00-11:10

Yes: Yaiji Sakamoto, Japan

11:10-11:20 No: Paisan Ruamviboonsuk, Thailand
11:20-11:30 Discussion
 

11:30-12:00

Debate III: New agents or delivery devices represents a clinically relevant advance in managing neovascular AMD

   

11:30-11:40

Yes: Jun Kong, China

11:40-11:50

No: Sherman Valero, Philippines

11:50-12:00

Discussion
 
12:00-12:15 Visit to Exhibits & Technical Break
 
12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
 
13:15-13:45 Visit to Exhibits - Dessert Break
 
13:45-15:15

RETINA II | Diabetic Macular Edema

Chairs: Xiaofeng Lin, China; Susan Bressler, USA 
13:45:14:15 Debate I: Consider alternative treatment regimens for patients with suboptimal vision responses after first 3 intravitreal anti-VEGF injections

13:45-13:55

Yes: Michaella Goldstein, Israel

13:55-14:05

No: Voraporn Chikitmongkol, Thailand

14:05-14:15

Discussion
 
14:15-14:45 Debate II: For persistent DME after 6 injections, add focal/grid laser
14:15-14:25 Yes: Jun Kong, China
14:25-14:35 No: Timothy Lai, Hong Kong
14:35-14:45 Discussion
 
14:45-15:15 Debate III: Artificial intelligence is ready to be used widely for DR Screening
14:45-14:55 Yes
14:55-15:05 No: Daniel Ting, Singapore
15:05-15:15 Discussion
 
15:15-16:45 RETINA III| Retinal Detachment and Vitrectomy
Chairs: Joseph Moisseiev, Israel; Taiji Sakamoto, Japan 
15:15-15:45 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy

15:15-15:25

Yes: Adrian Koh, Singapore

15:25-15:35

No: Taiji Sakamoto, Japan

15:35-15:45

Discussion
 
15:45-16:15 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye

15:45-15:55

Yes: Adiel Barak, Israel

15:55-16:05

No: Joseph Moisseiev, Israel

16:05-16:15

Discussion
 
16:15-16:45 Debate III: Attempt to treat focal vitreomacular traction with gas injection should be tried before considering vitrectomy
16:15-16:25 Yes: Shibo Tang, China
16:25-16:35 No: Adiel Barak, Israel
16:35-16:45 Discussion
 
   

SATURDAY, FEBRUARY 23, 2019

HALL A
   

09:00-10:00

Vision Academy in Retina 2019

Chairs:

 
 
09:00-09:10 An introduction to Vision Academy
 

09:10-09:30

Debate I: A fellow eye to an eye with actively treated CMV would best be monitored by sophisticated home monitoring technology (PHP, Home OCT)

09:10-09:15

Yes

09:15-09:20 No
09:20-09:25 Presentation of viewpoint

09:25-09:30

Questions
 

09:30-09:50

Debate II: Futility of treatment: In some cases in which no improvement is anticipated treatment should be stopped

09:30-09:35

Yes

09:35-09:40 No

09:40-09:45

Presentation of viewpoint

09:45-09:50

Questions
 
09:50-10:00 Looking forward with the Vision Academy
 
10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break
 
10:30-12:00

RETINA IV | Polypoidal Choroidal Vasculopathy

Chairs: Adrian Koh, Singapore; Won Ki Lee, South Korea 
10:30-11:00 Debate I: EVEREST 2 and PLANET results should be compared

10:30-10:40

Yes: Won Ki Lee, South Korea
10:40-10:50 No: Adrian Koh, Singapore

10:50-11:00

Discussion
 
11:00-11:30 Debate II: ICG Angiography is needed to manage most cases of PCV

11:00-11:10

Yes

11:10-11:20

No: Voroporn Chaikitmongkol, Thailand

11:20-11:30

Discussion

 
11:30-12:00 Debate III: OCT-Angiography is useful in management of PCV

11:30-11:40

Yes: Gemmy Cheung, Singapore

11:40-11:50

No: Timothy Lai, Hong Kong

11:50-12:00

Discussion
 
12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
 
12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
 
13:15-13:45 Visit to Exhibits - Dessert Break
 
13:45-15:15

RETINA V | Pathologic Myopia

Chairs: Hua Yan, China; Joseph Moisseiev, Israel 
13:45:14:15 Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia

13:45-13:55

Yes

13:55-14:05

No

14:05-14:15

Discussion
 
14:15-14:45 Debate II: Macular hemorrhage without leakage on fluorescein or ICG angiography should be treated empirically with anti-VEGF therapy or PDT with verteporfin for possible choroidal neovascularization obscured by hemorrhage

14:15-14:25

Yes: Young Hee Yoon, South Korea

14:25-14:35

No: Shibo Tang, China

14:35-14:45

Discussion
 
14:45-15:15 Debate III: Myopic foveoschisis should be treated by vitrectomy

14:45-14:55

Yes: Joseph Moissieiv, Israel

14:55-15:05

No: Adiel Barak, Israel

15:05-15:15

Discussion
 
15:15-16:45

RETINA VI | Retinal Vein Occlusions

Chairs: Xiaoling Liang, China; Timothy Lai, Hong Kong 
15:15-15:45 Debate I: Intravitreal steroids are a viable choice as first line therapy

15:15-15:25

Yes: Barry Kuppermann, USA

15:25-15:35

No: Gemmy Cheung, Singapore

15:35-15:45

Discussion
 
15:45-16:15 Debate II: SCORE 2 results: Choose aflibercept over bevacizumab for macular edema secondary to central retinal vein occlusion

15:45-15:55

Yes: Susan Bressler, USA

15:55-16:05

No: Young Hee Yoon, South Korea

16:05-16:15

Discussion
 
16:15-16:45 Debate III: Unilateral retinal vein occlusions in older individuals typically warrant work-up for systemic disease

16:15-16:25

Yes: Paisan Ruamviboonsuk, Thailand

16:25-16:35

No

16:35-16:45

Discussion
 
17:00-18:30

Think Tank: Controversies Across Ophthalmology

Chairs: Xiaxin Li, China; Tin Aung, Singapore; Paisan Ruamviboonsuk, Thailand 
17:00-17:30 Debate I: Removal of cataract increases the risk of progression of macular degeneration

17:00-17:10

Yes: Barry Kuppermann, USA

17:10-17:20

No

17:20-17:30

Discussion
 
17:30-18:00 Debate II: Big data are the next big thing in ophthalmology

17:30-17:40

Yes: Daniel Ting, Singapore

17:40-17:50

No: Sherman Valero, Philippines

17:50-18:00

Discussion
 
18:00-18:30 Spirinolactone is effective as a treatment for CSR

18:00-18:10

Yes

18:10-18:20

No: Michaella Goldstein, Israel

18:20-18:30

Discussion
   
   
 

GLAUCOMA

   

FRIDAY, FEBRUARY 22, 2019

HALL B
   
10:30-12:00

GLAUCOMA I | Screening and Monitoring Controversies

Chairs: Christopher Leung, Hong Kong
10:30-11:00 Debate I: MIGS is a passing fad

10:30-10:40

Yes

10:40-10:50

No: Christopher Leung, Hong Kong

10:50-11:00

Discussion
 
11:00-11:30 Debate II: Clear lens extraction is indicated for angle-closure glaucoma

11:00-11:10

Yes: Tin Aung, Singapore

11:10-11:20

No

11:20-11:30

Discussion
 
11:30-12:00 Debate III: Genetic profiling has a role in management of glaucoma

11:30-11:40

Yes

11:40-11:50

No

11:50-12:00

Discussion
 
12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
 
12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
 
13:15-13:45 Visit to Exhibits - Dessert Break
   
   
   

SATURDAY, FEBRUARY 23, 2019

HALL B
   
13:45-15:15

GLAUCOMA II | Management: Present and Future

Chairs: Ningli Wang, China; Ryo Asaoka, Japan
13:45:14:15 Debate I: Sustained release glaucoma systems will replace eye drops

13:45-13:55

Yes: Tin Aung, Singapore

13:55-14:05

No

14:05-14:15

Discussion
 
14:15-14:45 Debate II: Optic disc photography is outdated when we have OCT

14:15-14:25

Yes

14:25-14:35

No: Ryo Asaoka, Japan

14:35-14:45

Discussion
 
14:45-15:15 Debate III: Neuroprotective therapy for glaucoma will be available in the next 5 years

14:45-14:55

Yes: Christopher Leung, Hong Kong

14:55-15:05

No: Ryo Asaoka, Japan

15:05-15:10

Discussion
   
   
  ANTERIOR SEGMENT
   

FRIDAY, FEBRUARY 22, 2019

HALL B
   
13:45-15:15

ANTERIOR SEGMENT I | Cataract

Chairs: Ehud Assia, Israel
13:45:14:15 Debate I: High myopia is best corrected by clear lens extraction

13:45-13:55

Yes

13:55-14:05

No: Ehud Assia, Israel

14:05-14:15

Discussion
 
14:15-14:45 Debate II: Suture fixation is better than intraocular fixation of IOL

14:15-14:25

Yes

14:25-14:35

No: Shaowei Li, China

14:35-14:45

Discussion
 
14:45-15:15 Debate III: Presbyopic correction should be considered in all cataract operations

14:45-14:55

Yes

14:55-15:05

No: Danying Zheng, China

15:05-15:10

Discussion
 

SATURDAY, FEBRUARY 23, 2019

HALL B
   
14:00-15:30

ANTERIOR SEGMENT II | Cornea

Chairs:  
15:15-15:45 Debate I: Toric IOLs should be used only in eyes with corneal regular astigmatism

15:15-15:25

Yes

15:25-15:35

No: Ehud Assia, Israel

15:35-15:45

Discussion
 
15:45-16:15 Debate II: DMEK typically is better than DSAEK

15:45-15:55

Yes

15:55-16:05

No

16:05-16:15

Discussion
 
16:15-16:45 Debate III: Laser refractive surgery: Lasik typically should be chosen over SMILE for up to -12 diopters

16:15-16:25

Yes
16:25-16:35 No

16:35-16:45

Discussion
 
   
   
  NEURO-OPHTHALMOLOGY
   

FRIDAY, FEBRUARY 22, 2019

HALL B

   
15:15-16:45

NEURO-OPHTHALMOLOGY I | Afferent

Chairs:  Andrew Lee, USA

15:15-15:45

Debate I: There is treatment for traumatic optic neuropathy

15:15-15:25

Yes

15:25-15:35

No: Andrew Lee, USA

15:35-15:45

Discussion
 

15:45-16:15

Debate II: There is treatment for non-arteritic anterior ischemic optic neuropathy (NAION)

15:45-15:55

Yes: Andrew Lee, USA

15:55-16:05

No

16:05-16:15

Discussion
 

16:15-16:45

Case Presentations

 

Moderator: Andrew Lee, USA

Panelist: All Speakers

 
   
   
   

SATURDAY, FEBRUARY 23, 2019

HALL B

   

10:30-12:00

NEURO-OPHTHALMOLOGY II | Efferent

Chairs:  Andrew Lee, USA

10:30-11:00

Debate I: All patients with acute 6th nerve palsy should be imaged

10:30-10:40

Yes

10:40-10:50

No: Andrew Lee, USA

10:50-11:00

Discussion
 

11:00-11:30

Debate II: All patients with third nerve palsies should be imaged

11:00-11:10

Yes

11:10-11:20

No: Andrew Lee, USA

11:20-11:30

Discussion
 

11:30-12:00

Case Presentations

 

Moderator: Andrew Lee, USA

Panelist

 
12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
 
12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
 
13:15-13:45 Visit to Exhibits - Dessert Break

 

Veranstaltungsort:
Venue

Pudong Shangri-La
33 Fucheng Rd,
LuJiaZui,
Pudong Xinqu,
Shanghai Shi,
China, 200120
Anschrift:
Pudong Shangri-La 33 Fucheng Rd
200120 Shanghai Shi, China
Veranstalter:
Comtecmed
Organisation:

Comtecmed
53 Rothschild Boulevard
IL - 61000 Tel Aviv
Tel.: +972 (3) 566 6166
Fax: +972 (3) 566 6177

 
Hinweis:

 Registration required. For further information please contact the organizer.